TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Aurena Laboratories Holding AB
Closing information (x1000 DKK)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 147,146 | 140,976 | 122,682 |
Financial expenses | 1,103 | 687 | 463 |
Earnings before taxes | 9,206 | 7,401 | 6,667 |
EBITDA | 13,816 | 11,988 | 9,866 |
Total assets | 131,899 | 124,429 | 112,055 |
Current assets | 60,713 | 51,519 | 46,608 |
Current liabilities | 35,628 | 23,385 | 20,834 |
Equity capital | 69,564 | 69,236 | 65,550 |
- share capital | 334 | 364 | 371 |
Employees (average) | 76 | 76 | 74 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 52.7% | 55.6% | 58.5% |
Turnover per employee | 1,936 | 1,855 | 1,658 |
Profit as a percentage of turnover | 6.3% | 5.2% | 5.4% |
Return on assets (ROA) | 7.8% | 6.5% | 6.4% |
Current ratio | 170.4% | 220.3% | 223.7% |
Return on equity (ROE) | 13.2% | 10.7% | 10.2% |
Change turnover | 17,589 | 20,616 | -35,961 |
Change turnover % | 14% | 17% | -23% |
Chg. No. of employees | 0 | 2 | 1 |
Chg. No. of employees % | 0% | 3% | 1% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.